The impact of breast density on breast cancer risk and breast screening

Current Breast Cancer Reports

Volumn 4, Issue 2, 2012, Pages 161-168

  Houssami, Nehmat ^a   Kerlikowske, Karla ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast density; Interval cancer; Mammography. Population screening; Risk assessment; Ultrasound

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; BREAST EXAMINATION; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; COHORT ANALYSIS; DISEASE ASSOCIATION; ECHOMAMMOGRAPHY; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FALSE POSITIVE RESULT; FEASIBILITY STUDY; HUMAN; MAMMOGRAPHY; MEDICAL PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COUNSELING; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIMARY PREVENTION; PROGNOSIS; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STANDARDIZATION;

EID: 84863722388     PISSN: 19434588     EISSN: 19434596     Source Type: Journal    
DOI: 10.1007/s12609-012-0070-z     Document Type: Article

References (75)

1. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87:1622-9.
2. McCormack V, Dos Santos S. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159-69.
3. Vacek PM, Geller BM. Prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomark Prev. 2004;13(5):715-22.
4. Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006;98:1204-14.
5. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst. 2003;95:556-8.
6. Vachon C, Kuni C, Anderson K, Anderson V, Sellers T. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer. Cancer Causes Control. 2000;11:653-62.
7. Carney P, Miglioretti D, Yankaskas B, et al. Individual and combined effects of age, breast density and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168-75.
8. Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in postmenopausal women: Approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101:384-98.
9. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomark Prev. 1998;7:1133-44.
10. Warner E, Lockwood GA, Tritchler DL, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: A meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992;16:67-72.
11. Kerlikowske K. The mammogram that cried Wolfe. N Engl J Med. 2007;356:297-300.
12. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996;276:33-8.
13. Greendale GA, Reboussin BA, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med. 1999;130:262-9.
14. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomark Prev. 2002;11:1048-53.
15. White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by timein menstrual cycle among women aged 40 to 49 years. J Natl Cancer Inst. 1998;90:906-10.
16. Warwick J, Pinney E, Warren R, et al. Breast density and breast cancer risk factors in a high-risk population. Breast. 2003;12:10-6.
17. El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mamographic breast density by age. Cancer Causes Control. 2000;11:955-63.
18. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001;285:171-6.
19. Greendale G, Reboussin B, Slone S, et al. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003;95:30-7.
20. Reinier K, Vacek P, Geller B. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Res Treat. 2006;103:343-8.
21. MacKenzie T, Titus-Ernstoff L, Vacek P, et al. Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography. Cancer Causes Control. 2007;18:939-45.
22. Gill J, Maskarinec G, Pagano I, Kolonel L. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res. 2006;8:R30.
23. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomark Prev. 2004;13 (12):2090-5.
24. Ma H, Luo J, Press M, Wang Y, Bernstein L, Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triplenegative breast cancer. Cancer Epidemiol Biomark Prev. 2009;18 (2):479-85.
25. Aiello E, Buist D, White E, Porter P. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomark Prev. 2005;14:662-8.
26. Fasching PA, Heusinger K, Loehberg CR. Influence of mammographic breast density on the diagnotic accuracy of tumor size asessment and association iwth breast cancer tumor characteristics. Eur J Radiol. 2006;60:398-404.
27. Yang WT, Dryden M, Broglio K. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111:405-10.
28. Chen JH, Hsu F, Shih H. Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol. 2009;20:1447-9.
29. Conroy S, Pagano I, Kolonel L, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study. Cancer Epidemiol. 2011;Jan 17. [Epub ahead of print].
30. Ding J, Warren R, Girling A, Thompson D, Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J. 2010;16:279-89.
31. Yaghjyan L, Colditz GA, Collins L, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011;103(15):1179-89. This study highlights that breast density is associated with all subtypes of breast cancer.
32. Ma H, Wang Y, Sullivan-Halley J, et al. Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomark Prev. 2009;18:2214-20.
33. Ghosh K, Brandt K, Sellers T, et al. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomark Prev. 2008;17:872-9.
34. Porter G, Evans A, Cornford E, et al. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. AJR Am J Roentgenol. 2007;188:676-83.
35. Sala E, Solomon L, Warren R, et al. Size, node status and grade of breast tumours: Association with mammographic parenchymal patterns. Eur Radiol. 2000;10:157-61.
36. Roubidoux M, Bailey J, Wray L, Helvie M. Invasive cancers detected after breast cancer screening yielded a negative result: Relationship of mammographic density to tumor prognostic factors. Radiology. 2004;230:42-8.
37. Kerlikowske K, Cook A, Buist DSM, et al. Breast cancer risk by breast density, age, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28(24):3830-7. This work highlights the interaction between breast density, postmenopausal hormone therapy use, and the risk of breast cancer. It indicates that tumors in dense breasts may progress more rapidly than those in fatty breast.
38. Cil T, Fishell E, Hanna W, et al. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer. 2009;115(24):5780-7.
39. Habel L, Capra A, Achacoso N, et al. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2010;19:2488-95.
40. Habel LA, Dignam J, Land S, Salane M, Capra AM, Julian T. Mammographic density and breast cancer after ductal 1carcinoma in situ. J Natl Cancer Inst. 2004;96:1467-72.
41. Hwang ES, Miglioretti DL, Ballard-Barbash R, Weaver DL, Kerlikowske K. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2007;16(12):2587-93.
42. Park C, Rembert J, Moore D, Kerlikowske K. High mammographic breast density and obesity are associated with increased local recurrence following lumpectomy and radiation therapy for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009;73(1):75-9.
43. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148 (5):337-47. A risk prediction model (BCSC Breast Density 5-year risk model) that incorporates BI-RADS density with conventional risk factors (age, race, family history of breast cancer, history of breast biopsy) shows improved predictive accuracy with integration of density.
44. Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst. 2006;98(17):1215-26.
45. Ciatto S, Houssami N, Apruzzese A, et al. Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast. 2005;14:269-75.
46. Kerlikowske K, Grady D, Barclay J, et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). J Natl Cancer Inst. 1998;90:1801-9.
47. Shepherd J, Kerlikowske K, Ma L, et al. Volume of dense breast tissue and risk of breast cancer. Cancer Epidemiol Biomark Prev. 2011;20:1473-82 This study demonstrates the association between volumetric breast density and risk of breast cancer.
48. Marias K, Behrenbruch C, Highnam R, Parbhoo S, Seifalian A, Brady M. A mammographic image analysis method to detect and measure changes in breast density. Eur J Radiol. 2004;52:276-82.
49. Kaufhold J, Thomas J, Eberhard J, Galbo C, Trotter D. A calibration approach to glandular tissue composition estimation in digital mammography. Med Phys. 2002;29:1867-80.
50. Heine J, Fowler E, Flowers C. Full field digital mammography and breast density: Comparison of calibrated and noncalibrated measurements. Acad Radiol. 2011;18:1430-6.
51. Houssami N, Irwig L, Ciatto S. Radiological surveillance of interval breast cancers in screening programmes. Lancet Oncol. 2006;7 (3):259-65.
52. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081-7.
53. Chiarelli AM, Kirsh VA, Klar NS, et al. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol Biomark Prev. 2006;15 (10):1856-62.
54. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356 (3):227-36.
55. Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004;90(2):393-6.
56. Houssami N, Abraham LA, Miglioretti DL, et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305(8):790-9.
57. This study shows a signifcant association between density and breast screening outcomes in a very large cohort of women with a previous breast cancer. 57. Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E. Breast density and outcome of mammography screening: A cohort study. Br J Cancer. 2009;100(7):1205-8.
58. Kavanagh AM, Byrnes GB, Nickson C, et al. Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomark Prev. 2008;17(10):2818-24. This study demonstrates the association of breast density with risk of interval breast cancers in screening, and the association of increasing breast density with risk of cancers that have poorer prognosis.
59. Chiu SYH, Duffy S, Yen AMF, Tabar L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomark Prev. 2010;19(5):1219-28.
60. Schousboe J, Kerlikowske K, Loh A, Cummings S. Personalizing mammography by breast density and other risk factors for breast cancer: Analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155:10-20. This article presents a decisionanalytic evaluation of the benefits and harms of risk-based (defining risk with age, breast density, and family history) screening for breast cancer.
61. Cuzick J, Warwick J, Pinney E,Warren R, Duffy S. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004;96(8):621-8.
62. Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet. 2003;361 (9354):296-300.
63. Cuzick J, Warwick J, Pinney E, et al. Tamoxifen-Induced reduction in mammographic density and breast cancer risk reduction: A Nested Case-Control Study. J Natl Cancer Inst. 2011;103:744-52. This study shows that breast density's response to tamoxifen is associated with cancer outcome.
64. Kerlikowske K, Ichikawa L, Miglioretti D, et al. Longitudinal measurement of clinical mammographic breast density improves estimation of breast cancer risk. J Natl Cancer Inst. 2007;99:386-95.
65. Glasziou P, Houssami N. The evidence base for breast cancer screening. Prev Med. 2011;53(3).
66. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-83.
67. Houssami N, Lord SJ, Ciatto S. Breast cancer screening: Emerging role of new imaging techniques as adjuncts to mammography. Med J Aust. 2009;190(9):493-8.
68. Houssami N, Ciatto S. The evolving role of new imaging methods in breast screening. Prev Med. 2011;53(3):123-6.
69. Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MRI. 2000;21(4):325-36.
70. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001;221(3):641-9.
71. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations. Radiology. 2002;225(1):165-75.
72. Corsetti V, Houssami N, Ferrari A, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: Evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539-44.
73. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151-63.
74. Corsetti V, Houssami N, Ghirardi M, et al. Evidence of the effect of adjunct ultrasound screening in women withmammography-negative dense breasts: Interval breast cancers at one year follow-up. Eur J Cancer. 2011;47:1021-6. This article presents data on interval breast cancers in women with mammography-negative dense breasts who received ultrasound, suggesting a potential benefit.
75. Gram IT, Funkhouser E, Tabar L. The Tabar classification of mammographic parenchymal patterns. Eur J Radiol. 1997;24 (2):131-6.